Literature DB >> 22796018

Alcohol and cardiovascular disease: still unresolved underlying mechanisms.

Roberto Carnevale1, Cristina Nocella.   

Abstract

Alcoholic (ethanol-containing) beverages are consumed by most societies in the world. Low-to-moderate levels of ethanol consumption have been shown to reduce the risk of cardiovascular diseases and atherosclerosis. The decreased risk is likely due to alcohol's favorable pleiotropic effects on lipids, adhesion molecules, platelet activation and oxidative stress. However, there is also an abundance of clinical, experimental and epidemiological evidence showing that chronic high-dose ethanol consumption increases mortality, cardiovascular complications and also the progression of atherosclerosis. This last phenomenon appears to be due to the metabolism of ethanol, that leads to the formation of acetaldehyde, which is oxidized to acetate, leading to the generation of reactive oxygen species (ROS) and a toxic effect of ethanol on the formation of the atherosclerosis plaque. We will here briefly review the mechanisms through which high intakes of ethanol induce the formation of atherosclerotic plaque, focusing on increased oxidative stress as the main underlying mechanism.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796018     DOI: 10.1016/j.vph.2012.06.005

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  9 in total

1.  Acute alcohol consumption elevates serum bilirubin: an endogenous antioxidant.

Authors:  Stephanie S O'Malley; Ralitza Gueorguieva; Ran Wu; Peter I Jatlow
Journal:  Drug Alcohol Depend       Date:  2015-01-28       Impact factor: 4.492

2.  Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?

Authors:  Dong Hyun Sinn; Yong-Han Paik
Journal:  Clin Mol Hepatol       Date:  2014-06-30

3.  Effects of Moderate Ethanol Consumption on Lipid Metabolism and Inflammation Through Regulation of Gene Expression in Rats.

Authors:  Meegan Justice; Autumn Ferrugia; Joshua Beidler; Jerrold C Penprase; Patricia Cintora; Danielle Erwin; Octavio Medrano; Susan M Brasser; Mee Young Hong
Journal:  Alcohol Alcohol       Date:  2019-01-01       Impact factor: 2.826

4.  A snapshot of the hepatic transcriptome: ad libitum alcohol intake suppresses expression of cholesterol synthesis genes in alcohol-preferring (P) rats.

Authors:  Jonathon D Klein; Jeremy B Sherrill; Gabriella M Morello; Phillip J San Miguel; Zhenming Ding; Suthat Liangpunsakul; Tiebing Liang; William M Muir; Lawrence Lumeng; Amy C Lossie
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

5.  Associations of polymorphisms in TXNIP and gene-environment interactions with the risk of coronary artery disease in a Chinese Han population.

Authors:  Xue-Bin Wang; Ya-di Han; Shuai Zhang; Ning-Hua Cui; Ze-Jin Liu; Zhu-Liang Huang; Cong Li; Fang Zheng
Journal:  J Cell Mol Med       Date:  2016-07-29       Impact factor: 5.310

6.  Polymorphism in ERCC1 confers susceptibility of coronary artery disease and severity of coronary artery atherosclerosis in a Chinese Han population.

Authors:  Shuai Zhang; Xue-Bin Wang; Ya-di Han; Chen-Ling Xiong; Ye Zhou; Chen Wang; Ze-Jin Liu; Na Yang; Fang Zheng
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 7.  The relationship between mild alcohol consumption and mortality in Koreans: a systematic review and meta-analysis.

Authors:  Ji-Eun Park; Tae-young Choi; Yeonhee Ryu; Sung-Il Cho
Journal:  BMC Public Health       Date:  2015-09-18       Impact factor: 3.295

8.  Ethnic difference in the prevalence of angina pectoris in Sami and non-Sami populations: the SAMINOR study.

Authors:  Bent-Martin Eliassen; Sidsel Graff-Iversen; Marita Melhus; Maja-Lisa Løchen; Ann Ragnhild Broderstad
Journal:  Int J Circumpolar Health       Date:  2014-01-10       Impact factor: 1.228

9.  Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.

Authors:  Jean Strelitz; Amy L Ahern; Gráinne H Long; Clare E Boothby; Nicholas J Wareham; Simon J Griffin
Journal:  Cardiovasc Diabetol       Date:  2019-08-01       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.